Escalon Medical Corp.
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals for ophthalmology. Products include A-Scan, B-Scan, UBM, Pachymeter, and Ispan Intraocular Gases. The company also provides AXIS Image management system and disposable surgical packs for vitreoretinal surgery. Additionally, it manufactures and distributes a patented universal gas kit. Escalon sells its products to medical institutions through sales reps, distributors, and internal employees. The company was incorporated in 1987 and is headquartered in Pennsylvania.
Overview
Strengths
- Pricing power: gross margin has held between 42% and 46% over the last 6 years (latest 45.7%).
- Our discounted cash flow model points to 132% upside (target price 0.44 USD), and even our pessimistic growth scenario implies 103%: a margin of safety.
- Valued below its Medical Devices peers: P/E 13.4x vs. a median of 31.7x, P/FCF 3.7x vs. a median of 28.1x and EV/EBITDA 6.8x vs. a median of 17.1x.
- ROIC of 17.4% beats 82% of its 51 Medical Devices peers (median 9.6%).
- Cheaper than its own history: P/E 13.4x vs. a historical average of 59.3x, P/FCF 3.7x vs. a historical average of 51.6x and EV/EBITDA 6.8x vs. a historical average of 29.3x.
- Trades below book value (price-to-book 0.74x).
Weaknesses
- Unreliable cash generation: free cash flow was negative in 3 of the last 6 years.
- Unstable profitability: operating margin ranged from -8% to 4% over the last 6 years, with operating losses in 4 of them.
- Small company (enterprise value $1.1 million): thinner analyst coverage, lower liquidity and wider valuation uncertainty.
Key Financial Data